MGMarina Gertsenstein

Marina Gertsenstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marina Gertsenstein has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-read RNA sequencing identifies non-coding isoform switching as a regulator of cell fate

    by Victoire Fort, Gabriel Khelifi, Ruicen He, Valérie Watters, Melanie Pye, Nobuko Yamanaka, Marina Gertsenstein, Émeline I. J. Lelong, Jérémy Loehr, Victoria Micha, et al.

    Development of long-read RNA sequencing technologies has paved the way to the exploration of RNA isoform diversity and its relevance in regulating cell fate. However, identifying new functional isoforms is still very difficult. Here, we leverage long-read RNA sequencing to study changes in isoforms during somatic cell reprogramming and identify novel isoforms occurring throughout cell state transitions. We demonstrate tight regulation of non-coding isoforms and show that isoform switching plays previously overlooked functional roles and outcomes in gene regulation and cell fate changes. We uncover a novel long non-coding RNA, Snhg26 , that undergoes isoform switching during reprogramming to enhance the conversion of differentiated cells towards the pluripotent state. Knock-down of Snhg26 in mouse and human pluripotency models reveals that it is important for pluripotency acquisition. Together, our study provides a resource to study full-length isoform usage during cell fate change. It also demonstrates the power of long-read sequencing to identify functionally relevant gene isoforms in the context of cell plasticity.


  • Open Access

    Cover Image, Volume 36, Issue 5

    by Liam T. Ralph, Shinwon Kang, Lauren A. Joe, Patrick Tidball, Ahmad R. Israwi, Meng Tian, Ashish Kadia, Lijia Zhang, Fuzi Jin, Rachael Ingram, et al.

  • Open Access

    Diurnal Regulation of Hippocampal Synaptic Plasticity in Aged Rats and the Role of the Circadian Clock Gene Per1

    by Liam T. Ralph, Shinwon Kang, Lauren A. Joe, Patrick Tidball, Ahmad R. Israwi, Meng Tian, Ashish Kadia, Lijia Zhang, Fuzi Jin, Rachael Ingram, et al.

    Period circadian regulator 1 (PER1) regulates circadian gene expression and is critical for spatial memory. However, its role in regulating synaptic plasticity between diurnal phases remains largely unknown. Here, we examined long‐term potentiation (LTP) and long‐term synaptic depression (LTD) in hippocampal slices prepared from aged male Per1 knockout ( Per1 KO) rats and their wildtype (WT) littermates during the light/inactive and dark/active phases. In WT rats, theta‐burst stimulation (TBS) consistently induced stable LTP that was greater during the dark relative to the light phase. In contrast, in Per1 KO rats, TBS resulted in synaptic potentiation that decayed to baseline levels within ~90 min in both phases. Notably, WT rats readily expressed LTD following 1 Hz low‐frequency stimulation (LFS) during the dark phase but not the light phase. By comparison, in Per1 KO rats, LTD was inducible by LFS during both the dark and light phases. LTD in both WT and Per1 KO rats was dependent on the activation of N ‐methyl‐ d ‐aspartate receptors. Basal synaptic transmission was reduced and GluA1 S845 phosphorylation was increased during the dark phase in both WT and Per1 KO rats. Together, our findings identify PER1 as a key regulator of synaptic plasticity between diurnal phases in aged rats.

  • Open Access

    Visible traits demonstrate that crispant founder mice can be used for phenotypic assessment

    by Rebekah Tillotson, Marina Gertsenstein, Li-Hsin Chang, Julie Ruston, Fernando Bellido Molías, Lauri G Lintott, Christine Taylor, Philippe Gautier, Lauryl Mj Nutter, Monica J Justice

    Genes can be knocked out in model organisms by introducing a single guide RNA and Cas9 into one cell zygotes. Recently, the zebrafish and Xenopus communities have employed this method in genetic screening pipelines that assess phenotypes in founders (F0), referred to as “crispants”. In contrast, phenotyping crispant mice has been avoided as results are believed to be confounded by genetic mosaicism, requiring that only established mouse lines undergo phenotypic assessment. Here, we targeted seven genes associated with visible recessive phenotypes. We observed the expected null phenotype in up to 100% founders per gene. Crucially, we achieved 100% editing efficiency in all but two animals. Genetic mosaicism was common, but did not confound an animal’s phenotype when comprised of mutations that all disrupted the targeted gene. Mosaicism included short in-frame mutations, but these were sufficient to disrupt function of five genes. Several founders were compound heterozygotes carrying a null and a non-null allele (short in-frame mutation or late truncation), enabling functional assessment of the non-null allele to dissect protein function. Our results set the stage for using crispant founders for initial phenotypic assessment in genetic screening, before selecting candidates for further study. This will dramatically reduce animal numbers.

  • Open Access

    Tau deletion results in sex-dependent modulation of synaptic weakening in rat hippocampus

    by Liam T. Ralph, Patrick Tidball, Eric W. Salter, Brian Park, Lijia Zhang, Mengdi Wei, Lauren A. Joe, Jonathan S. Thacker, Sun-Lim Choi, Ashish Kadia, et al.

    Tangles, a defining characteristic of Alzheimer’s disease ( AD ), are composed principally of hyperphosphorylated and misfolded tau species. However, dysregulation of tau precedes tangle formation by many years and is associated with cognitive decline, the best functional correlate of which is synaptic weakening and eventual synaptic loss. Although tau is present at synapses, its normal synaptic function is poorly understood – information vital to the rational development of tau-modifying therapies. Since rats have a greater cognitive repertoire than mice and display more robust signs of tau pathology in AD models, we developed a tau knockout ( Mapt -/- ) rat to investigate the impact of tau elimination on synaptic function. We observed that long-term depression ( LTD ), a form of synaptic weakening, is enhanced in the hippocampus of male, but not female, rats. This enhanced LTD was dependent on the synaptic activation of group I metabotropic glutamate receptors and involved altered synaptic actin polymerization. These studies therefore provide mechanistic insights into how tau modulates synaptic function via regulation of the actin cytoskeleton. Our findings are relevant to the understanding of the physiological roles of synaptic tau, the functional consequences of tau-lowering therapies, and the influence of sex in AD susceptibility.

  • Open Access

    Visible traits demonstrate that crispant founder mice can be used for phenotypic assessment

    by Rebekah Tillotson, Marina Gertsenstein, Li-Hsin Chang, Julie Ruston, Fernando Bellido Molías, Lauri G. Lintott, Christine Taylor, Philippe Gautier, Lauryl M. J. Nutter, Monica J. Justice

    Genes can be knocked out in model organisms by introducing a single guide RNA and Cas9 into one cell zygotes. Recently, the zebrafish and Xenopus communities have employed this method in genetic screening pipelines that assess phenotypes in founders (F0), referred to as “crispants”. In contrast, phenotyping crispant mice has been avoided as results are believed to be confounded by genetic mosaicism, requiring that only established mouse lines undergo phenotypic assessment. Here, we targeted seven genes associated with visible recessive phenotypes. We observed the expected null phenotype in up to 100% founders per gene. Crucially, we achieved 100% editing efficiency in all but two animals. Genetic mosaicism was common, but did not confound an animal’s phenotype when comprised of mutations that all disrupted the targeted gene. Mosaicism included short in-frame mutations, but these were sufficient to disrupt function of five genes. Several founders were compound heterozygotes carrying a null and a non-null allele (short in-frame mutation or late truncation), enabling functional assessment of the non-null allele to dissect protein function. Our results set the stage for using crispant founders for initial phenotypic assessment in genetic screening, before selecting candidates for further study. This will dramatically reduce animal numbers.

  • Open Access

    Long-read RNA sequencing identifies non-coding isoform switching as a regulator of cell fate

    by Victoire Fort, Gabriel Khelifi, Ruicen He, Valérie Watters, Melanie Pye, Nobuko Yamanaka, Marina Gertsenstein, Émeline I. J. Lelong, Jérémy Loehr, Victoria Micha, et al.

    Development of long-read RNA sequencing technologies has paved the way to the exploration of RNA isoform diversity and its relevance in regulating cell fate. However, identifying new functional isoforms is still very difficult. Here, we leverage long-read RNA sequencing to study changes in isoforms during somatic cell reprogramming and identify novel isoforms occurring throughout cell state transitions. We demonstrate tight regulation of non-coding isoforms and show that isoform switching plays previously overlooked functional roles and outcomes in gene regulation and cell fate changes. We uncover a novel long non-coding RNA, Snhg26 , that undergoes isoform switching during reprogramming to enhance the conversion of differentiated cells towards the pluripotent state. Knock-down of Snhg26 in mouse and human pluripotency models reveals that it is important for pluripotency acquisition. Together, our study provides a resource to study full-length isoform usage during cell fate change, and demonstrates the power of long-read sequencing to identify functionally relevant gene isoforms in the context of cell plasticity.

  • The development and characterization of a CRISPR/Cas9-mediated PD-1 functional knockout rat as a tool to study idiosyncratic drug reactions

    by Tiffany Cho, Antonia Wierk, Marina Gertsenstein, Christopher E Rodgers, Jack Uetrecht, Jeffrey T Henderson

    Idiosyncratic drug reactions are rare but serious adverse drug reactions unrelated to the known therapeutic properties of the drug and manifest in only a small percentage of the treated population. Animal models play an important role in advancing mechanistic studies examining idiosyncratic drug reactions. However, to be useful, they must possess similarities to those seen clinically. Although mice currently represent the dominant mammalian genetic model, rats are advantageous in many areas of pharmacologic study where their physiology can be examined in greater detail and is more akin to that seen in humans. In the area of immunology, this includes autoimmune responses and susceptibility to diabetes, in which rats more accurately mimic disease states in humans compared with mice. For example, oral nevirapine treatment can induce an immune-mediated skin rash in humans and rats, but not in mice due to the absence of the sulfotransferase required to form reactive metabolites of nevirapine within the skin. Using CRISPR-mediated gene editing, we developed a modified line of transgenic rats in which a segment of IgG-like ectodomain containing the core PD-1 interaction motif containing the native ligand and therapeutic antibody domain in exon 2 was deleted. Removal of this region critical for mediating PD-1/PD-L1 interactions resulted in animals with an increased immune response resulting in liver injury when treated with amodiaquine.


  • Open Access

    Highly efficient reprogrammable mouse lines with integrated reporters to track the route to pluripotency

    by Judith Elbaz, Mira C. Puri, Maryam Faiz, K. W. Annie Bang, Lena Nguyen, Bar Makovoz, Marina Gertsenstein, Samer M. I. Hussein, Peter W. Zandstra, Laurent Briollais, et al.

    Revealing the molecular events associated with reprogramming different somatic cell types to pluripotency is critical for understanding the characteristics of induced pluripotent stem cell (iPSC) therapeutic derivatives. Inducible reprogramming factor transgenic cells or animals—designated as secondary (2°) reprogramming systems—not only provide excellent experimental tools for such studies but also offer a strategy to study the variances in cellular reprogramming outcomes due to different in vitro and in vivo environments. To make such studies less cumbersome, it is desirable to have a variety of efficient reprogrammable mouse systems to induce successful mass reprogramming in somatic cell types. Here, we report the development of two transgenic mouse lines from which 2° cells reprogram with unprecedented efficiency. These systems were derived by exposing primary reprogramming cells containing doxycycline-inducible Yamanaka factor expression to a transient interruption in transgene expression, resulting in selection for a subset of clones with robust transgene response. These systems also include reporter genes enabling easy readout of endogenous Oct4 activation (GFP), indicative of pluripotency, and reprogramming transgene expression (mCherry). Notably, somatic cells derived from various fetal and adult tissues from these 2° mouse lines gave rise to highly efficient and rapid reprogramming, with transgene-independent iPSC colonies emerging as early as 1 wk after induction. These mouse lines serve as a powerful tool to explore sources of variability in reprogramming and the mechanistic underpinnings of efficient reprogramming systems.


  • Administration of Gonadotropins for Superovulation in Mice

    by Richard Behringer, Marina Gertsenstein, Kristina Vintersten Nagy, Andras Nagy

    For experiments that require large numbers of preimplantation mouse embryos, such as microinjection of zygotes, gonadotropins are administered to females before mating to increase the number of oocytes that are ovulated (i.e., to induce superovulation). Pregnant mare serum gonadotropin (PMSG) is used to mimic the oocyte maturation effect of the endogenous follicle-stimulating hormone (FSH), and human chorionic gonadotropin (hCG) is used to mimic the ovulation induction effect of luteinizing hormone (LH).